Proteomics pinpoints alterations in grade I meningiomas of male versus female patients

[1]  A. Mes-Masson,et al.  CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis. , 2019, American Journal of Pathology.

[2]  K. Aldape,et al.  Proteomic analysis of meningiomas reveals clinically-distinct molecular patterns. , 2019, Neuro-oncology.

[3]  Johannes A Eble,et al.  The extracellular matrix in tumor progression and metastasis , 2019, Clinical & Experimental Metastasis.

[4]  F. Mollinedo.  Neutrophil Degranulation, Plasticity, and Cancer Metastasis. , 2019, Trends in immunology.

[5]  M. Futschik,et al.  Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism , 2018, EBioMedicine.

[6]  M. Grigorian,et al.  The Multifaceted S100A4 Protein in Cancer and Inflammation. , 2019, Methods in molecular biology.

[7]  N. Lee,et al.  Aberrant RNA Splicing in Cancer and Drug Resistance , 2018, Cancers.

[8]  Jinhua Zhang,et al.  S100a4 promotes the development of lipopolysaccharide-induced mouse endometritis† , 2018, Biology of Reproduction.

[9]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. , 2018, Neuro-oncology.

[10]  A. E. del Río Hernández,et al.  Role of Extracellular Matrix in Development and Cancer Progression , 2018, International journal of molecular sciences.

[11]  I. Shin,et al.  Role of the CCN protein family in cancer , 2018, BMB reports.

[12]  J. Ansari,et al.  Intracranial meningioma as primary presentation for an undiagnosed collision metastatic breast cancer: Case report and literature review. , 2018, Molecular and clinical oncology.

[13]  J. Raizer,et al.  Recent advances in managing/understanding meningioma , 2018, F1000Research.

[14]  M. Osswald,et al.  Meningiomas: Overview and New Directions in Therapy , 2018, Seminars in Neurology.

[15]  Juliana de Saldanha da Gama Fischer,et al.  Comparing intestinal versus diffuse gastric cancer using a PEFF-oriented proteomic pipeline. , 2018, Journal of proteomics.

[16]  Yifeng Wang,et al.  Frequency dependent hub role of the dorsal and ventral right anterior insula , 2018, NeuroImage.

[17]  Jixin Zhong,et al.  S100 Proteins As an Important Regulator of Macrophage Inflammation , 2018, Front. Immunol..

[18]  Yu You,et al.  Antitumor activity of Notch-1 inhibition in human colorectal carcinoma cells , 2017, Oncology reports.

[19]  Gilberto B. Domont,et al.  DiagnoProt: a tool for discovery of new molecules by mass spectrometry , 2017, Bioinform..

[20]  Shiwu Zhang,et al.  S100A4 in cancer progression and metastasis: A systematic review , 2017, Oncotarget.

[21]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[22]  A. Brodbelt,et al.  Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response , 2016, British Journal of Cancer.

[23]  John R Yates,et al.  Integrated analysis of shotgun proteomic data with PatternLab for proteomics 4.0 , 2015, Nature Protocols.

[24]  Henning Hermjakob,et al.  The Reactome pathway Knowledgebase , 2015, Nucleic acids research.

[25]  Garima,et al.  The Role of p53 Gene in Cervical Carcinogenesis , 2016, The Journal of Obstetrics and Gynecology of India.

[26]  Joshua B. Rubin,et al.  An integrative view on sex differences in brain tumors , 2015, Cellular and Molecular Life Sciences.

[27]  C. Scafoglio,et al.  Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells , 2015, BMC Genomics.

[28]  E. Cukierman,et al.  Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer. , 2015, Trends in biotechnology.

[29]  Sandipan Ray,et al.  Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers , 2014, Scientific Reports.

[30]  Meixiao Shen,et al.  Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis , 2014, PloS one.

[31]  A. Goldbeter,et al.  The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition , 2014, Interface Focus.

[32]  Ben Tran,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[33]  Zhihua Liu,et al.  S100 protein family in human cancer. , 2014, American journal of cancer research.

[34]  Xing-Hua Liao,et al.  Estrogen receptor α mediates proliferation of breast cancer MCF–7 cells via a p21/PCNA/E2F1‐dependent pathway , 2014, The FEBS journal.

[35]  L. Byers,et al.  Smoking, p53 Mutation, and Lung Cancer , 2014, Molecular Cancer Research.

[36]  María Martín,et al.  Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..

[37]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[38]  B. Zhivotovsky,et al.  S100A4 interacts with p53 in the nucleus and promotes p53 degradation , 2013, Oncogene.

[39]  J. Xiang,et al.  The clinical and prognostic significance of CCN3 expression in patients with cervical cancer. , 2013, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[40]  L. Crawford,et al.  The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia , 2013, The Journal of pathology.

[41]  X. G. Li,et al.  Proteomic analysis of meningiomas , 2013, Acta Neurologica Belgica.

[42]  Johannes Griss,et al.  The Proteomics Identifications (PRIDE) database and associated tools: status in 2013 , 2012, Nucleic Acids Res..

[43]  The UniProt Consortium,et al.  Update on activities at the Universal Protein Resource (UniProt) in 2013 , 2012, Nucleic Acids Res..

[44]  A. B. Grayeli,et al.  Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. , 2012, Neuro-oncology.

[45]  Valmir Carneiro Barbosa,et al.  Improving the TFold test for differential shotgun proteomics , 2012, Bioinform..

[46]  Shuai Liu,et al.  CCN3 (NOV) regulates proliferation, adhesion, migration and invasion in clear cell renal cell carcinoma. , 2012, Oncology letters.

[47]  P. Ray,et al.  Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease , 2012, FEBS letters.

[48]  John R Yates,et al.  Search engine processor: Filtering and organizing peptide spectrum matches , 2012, Proteomics.

[49]  Tien-Huang Lin,et al.  CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells. , 2012, Carcinogenesis.

[50]  M. Seiki,et al.  Cell Adhesion in Cancer , 2012, International journal of cell biology.

[51]  A. Ziemienowicz,et al.  Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. , 2011, Annals of botany.

[52]  Mehdi Mirzaei,et al.  Less label, more free: Approaches in label‐free quantitative mass spectrometry , 2011, Proteomics.

[53]  Elias Bareinboim,et al.  Bioinformatics Applications Note Analyzing Marginal Cases in Differential Shotgun Proteomics , 2022 .

[54]  D. Monleón,et al.  Metabolic aggressiveness in benign meningiomas with chromosomal instabilities. , 2010, Cancer research.

[55]  Joseph Wiemels,et al.  Epidemiology and etiology of meningioma , 2010, Journal of Neuro-Oncology.

[56]  S. Almo,et al.  S100A4 Regulates Macrophage Chemotaxis , 2010, Molecular biology of the cell.

[57]  Kjetil Boye,et al.  S100A4 and metastasis: a small actor playing many roles. , 2010, The American journal of pathology.

[58]  Jui-wei Lin,et al.  Breast carcinoma metastasis to intracranial meningioma , 2009, Journal of Clinical Neuroscience.

[59]  C. Naus,et al.  Matricellular Protein CCN3 (NOV) Regulates Actin Cytoskeleton Reorganization* , 2009, The Journal of Biological Chemistry.

[60]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[61]  A. Tyson-Capper,et al.  Alternative splicing and the progesterone receptor in breast cancer , 2008, Breast Cancer Research.

[62]  F. Umansky,et al.  Radiation-induced meningioma. , 2008, Neurosurgical focus.

[63]  D. Elder,et al.  Downregulation of CCN3 expression as a potential mechanism for melanoma progression , 2008, Oncogene.

[64]  F. Sedaghat,et al.  S100 protein family and its application in clinical practice. , 2008, Hippokratia.

[65]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[66]  A. Ori,et al.  Antiproliferative activity of CCN3: Involvement of the C‐terminal module and post‐translational regulation , 2007, Journal of cellular biochemistry.

[67]  N. Borregaard,et al.  Neutrophil granules: a library of innate immunity proteins. , 2007, Trends in immunology.

[68]  J. Yates,et al.  Interaction of estrogen receptor α with proliferating cell nuclear antigen , 2007, Nucleic acids research.

[69]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[70]  N. Xu,et al.  Lipids changes in liver cancer , 2007, Journal of Zhejiang University SCIENCE B.

[71]  C. Heizmann,et al.  The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. , 2006, Gastroenterology.

[72]  A. Vortmeyer,et al.  Comparative proteomic profiles of meningioma subtypes. , 2006, Cancer research.

[73]  Michael K. Coleman,et al.  Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. , 2006, Journal of proteome research.

[74]  A. Kornblihtt,et al.  The connection between splicing and cancer , 2006, Journal of Cell Science.

[75]  T. Koepsell,et al.  Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study , 2006, BMC Cancer.

[76]  P. Black,et al.  Epidemiology of intracranial meningioma. , 2005, Neurosurgery.

[77]  N. Planque,et al.  CCN proteins and cancer: two to tango. , 2005, Frontiers in bioscience : a journal and virtual library.

[78]  Y. Le Bouc,et al.  Characterization of human NOV in biological fluids: an enzyme immunoassay for the quantification of human NOV in sera from patients with diseases of the adrenal gland and of the nervous system. , 2003, The Journal of clinical endocrinology and metabolism.

[79]  Chang Long Li,et al.  A role for CCN3 (NOV) in calcium signalling , 2002, Molecular pathology : MP.

[80]  P. Picci,et al.  The expression of ccn3(nov) gene in musculoskeletal tumors. , 2002, The American journal of pathology.

[81]  T. Crook,et al.  The p53 pathway in breast cancer , 2002, Breast Cancer Research.

[82]  P. Rudland,et al.  S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes , 2002, British Journal of Cancer.

[83]  R. Weichselbaum,et al.  Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV) , 2001, Molecular pathology : MP.

[84]  J. Winstanley,et al.  Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. , 2000, Cancer research.

[85]  J. Bertram,et al.  Molecular Biology of Cancer , 1997, Nature Medicine.

[86]  E. Hedley‐Whyte,et al.  Progesterone and estrogen receptors in meningiomas: prognostic considerations. , 1997, Journal of neurosurgery.

[87]  G. Cooper.  The Cell: A Molecular Approach , 1996 .

[88]  P. Kleihues,et al.  The p53 gene and its role in human brain tumors , 1995, Glia.